Path to Sarepta Therapeutic (SRPT) Eteplirsen Filing Taking Shape - Needham & Company

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. QCOM
2. FDX
3. CBRS
4. USO
5. SPY
6. MU
7. KBH
8. HON
9. HTZ
10. JPM

Go back to Path to Sarepta Therapeutic (SRPT) Eteplirsen Filing Taking Shape - Needham & Company

Sarepta Therapeutics (SRPT) Posts Q1 Loss of 75c/Share

May 8, 2014 7:00 AM EDT

Sarepta Therapeutics (NASDAQ: SRPT) reported Q1 EPS of ($0.75), $0.05 better than the analyst estimate of ($0.80). Revenue for the quarter came in at $6.09 million versus the consensus estimate of $3.45 million.

For earnings history and earnings-related data on Sarepta Therapeutics (SRPT) click here.

... More